Search

everythinglearnresearchcommunity

for

Search:↓

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Estrogen increases a growth factor in hair cells which might affect hair loss.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

KRT17 may be a new target for endometrial cancer treatment because it helps cancer cells move and form new blood vessels.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

Topical estrogen helps hair growth in menopausal women with no major side effects.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

Higher DHT in male baldness may protect against prostate cancer.

Finasteride use may increase the risk of male breast cancer.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

A group has developed therapies that show promise for treating cancer and various other conditions.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Activating ER-β, not ER-α, improves skin cell growth and wound healing.

Researchers found a gene in hamsters that responds to male hormones and may be indirectly controlled by them.

Matriptase is crucial for keeping epithelial tissues healthy and functioning properly.